Background The use of warfarin in patients with atrial fibrillation (AF) and chronic kidney
disease (CKD) can be problematic because of increased bleeding risk. We performed a …

Purpose The findings from the observational studies comparing the effectiveness and safety
of non–vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists …

Atrial fibrillation (AF) is the commonest cardiac rhythm abnormality and has a significant
disease burden. Amongst its devastating complications is stroke, the risk of which increases …

Type 2 diabetes mellitus is one of the most common chronic conditions and its prevalence
has increased continuously over the past decades, primarily due to the obesity epidemic …

The prevalence of heart failure (HF) is skyrocketing worldwide, and is closely associated
with serious morbidity and mortality. In particular, HF is one of the main causes for the …

Background Atrial fibrillation (AF) in the elderly is a complex condition. It has a direct impact
on the underuse of antithrombotic therapy reported in this population. Discussion All patients …

The novel oral anticoagulants or direct oral anticoagulants (DOAC) are becoming more
common in clinical practice for the prevention of stroke in non-valvular atrial fibrillation …

Stroke prevention is a key clinical concern in the management of patients with atrial
fibrillation. Oral anticoagulation treatment reduces the risk of disabling stroke, but the …

Aims Iron deficiency (ID) occurs in about 50% of patients with heart failure (HF). The
European Society of Cardiology (ESC) recommends ID diagnostic testing in newly …

Atrial fibrillation (AF) remains the most frequent sustained cardiac arrhythmia worldwide and
its incidence increases with ageing, cardiovascular risk factors and comorbidities …